What I think is next for Standard Chartered’s dividend

Jay Yao writes what he thinks Standard Chartered management might do with the dividend given the recent approval of the Pfizer vaccine

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Like several other leading British banks, Standard Chartered (LSE: STAN) suspended its dividend earlier in the year because of the pandemic. 

British regulators were concerned about the highly uncertain and economically destructive impact of the coronavirus, and asked banks to not pay out dividends. Standard Chartered canceled its planned final fiscal year 2019 dividend of $0.2 per share.

The dividend suspension worsened the already bearish sentiment around STAN and likely sent the stock lower. Recently, however, things have improved. 

In December, Britain and the US both approved a Covid-19 vaccine from Pfizer that’s around 95% effective. Several more vaccine candidates could be approved soon. 

STAN itself has made something of a comeback as hope builds for the beginning of economic normalization next year. Since late October, shares have risen over 37%. 

Given the stock comeback, here’s what I think will happen next for Standard Chartered’s dividend. 

Reasons I believe Standard Chartered will pay a dividend 

I reckon the odds that Standard Chartered resumes its dividend sometime in the next year are very good.

First, British regulators at the Bank of England are more open to bank dividend payments now that a Covid-19 vaccine exists. Britain’s Prudential Regulation Authority (PRA) recently saidWeighing those considerations, and consistent with the PRA’s view that distributions are an important and necessary part of the functioning of the banking system, the PRA judges that an extension of the exceptional and precautionary action taken in March is not necessary”.

Second, STAN’s financials are strong enough to support a dividend, in my view. The bank is strongly capitalised, with a CET1 ratio of 14.4%. It is also profitable. For the third quarter, Standard Chartered reported earnings per share of 13.6 cents. I reckon there is a pretty decent chance the bank’s earnings could also increase.

Growth in emerging and developing markets in Asia could rebound rather quickly. For example, in an October report, the IMF estimated emerging and developing Asia will grow 8% in 2021. This is up from an estimated shrinkage of 1.7% in 2020. Standard Chartered gets a lot of its profits from Asia. 

Management themselves have also said that they may resume shareholder returns next year, which presumably could include dividends. 

Dividend amount?  

In terms of how much Standard Chartered could pay in dividends next year, it’s uncertain. For 2019, STAN reported underlying earnings per share of 75.7 cents. The board originally intended to pay a total ordinary dividend per share of 27 cents. That gives Standard Chartered an intended 2019 payout ratio of 35.67%.

For fiscal year 2021, if STAN earns the estimated $0.61 per share that analysts expect, and management maintains the same payout ratio of 35.67%, the bank would pay around $0.22 per share. 

Given there is still a lot of uncertainty, however, I think Standard Chartered might pay a lower annual dividend, at least for next year. Interest rates are still low, and the manufacturing and distribution of Covid-19 vaccines will be a difficult process. 

No matter what the final dividend amount next year, however, I’d still buy the stock given its low price to book value ratio of 0.44. I reckon the stock could increase if management executes and interest rates normalize. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Jay Yao has no position in any of the shares mentioned. The Motley Fool UK has recommended Standard Chartered. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »